Xi'an Mokemei Biotechnology: difference between revisions
Diff·revision 10 → 11·13:08, 18 Jun 2025
Difference between revision 10 and revision 11 of Xi'an Mokemei Biotechnology. 8 lines changed; the page grew by 732 bytes.
| Revision 10 — 12:56, 9 Jun 2025 Ref_Desk_Ron (talk) correct the other-designations row — those are trading variants, not subsidiaries 6,325 bytes +538 | Revision 11 — 13:08, 18 Jun 2025 IncretinIvo (talk) serial comma per PP:MOS 7,057 bytes +732 | ||
|---|---|---|---|
| 12 | | Industry = Research-compound supply | 12 | | Industry = Research-compound supply |
| 13 | | Official site = [https://mokemeibiotechnology.com/ Visit MKM at mokemeibiotechnology.com] | 13 | | Official site = [https://mokemeibiotechnology.com/ Visit MKM at mokemeibiotechnology.com] |
| + | 14 | <!-- Products and documentation --> | |
| + | 15 | | Product scope = peptides, SARMs, injectable oils and raw materials | |
| + | 16 | | Catalogue size = 350+ listings (self-reported) | |
| + | 17 | | Documentation = Batch certificate of analysis reported with orders | |
| + | 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record | |
| 14 | }} | 19 | }} |
| 15 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| ⋮ | ⋮ | ||
| 43 | 48 | ||
| 44 | The extract-derived listings sit in a different analytical world from synthetic peptides: a standardised extract is characterised by marker-compound assay rather than by [[Area percent purity|area percent]] of a single species, and a purity figure on such a material means something different.{{r|selfpub}} | 49 | The extract-derived listings sit in a different analytical world from synthetic peptides: a standardised extract is characterised by marker-compound assay rather than by [[Area percent purity|area percent]] of a single species, and a purity figure on such a material means something different.{{r|selfpub}} |
| + | 50 | ||
| + | 51 | == Independent testing record == | |
| + | 52 | Submitted reports on MKM material to July 2026 cover the incretin range and a small number of repair peptides. Reported [[Area percent purity|area percent]] figures have been high across the set, and where an independent report and the accompanying certificate could be placed side by side the two have agreed within the range that different separations account for.{{r|reports}} | |
| 45 | 53 | ||
| 46 | == References == | 54 | == References == |